The role of microRNAs in congenital heart disease

Area of Science:

• Developmental Biology
• Genetics and Epigenetics
• Cardiovascular Research

Background:

• Congenital heart diseases (CHDs) are the primary inherited cause of infant mortality, involving structural heart and blood vessel anomalies.
• Improved treatments have increased CHD patient lifespan, necessitating deeper understanding of disease mechanisms for better diagnosis and prognosis.
• While genetic factors are known, epigenetic changes, particularly microRNAs (miRs), are increasingly recognized in CHD development.

Purpose of the Study:

• To review the current understanding of microRNAs' (miRs) role in cardiac development.
• To discuss the causative involvement of miRs in congenital heart diseases (CHDs).
• To highlight the potential of miRs as diagnostic markers and therapeutic targets for CHDs.

Main Methods:

• Review of existing scientific literature and experimental data.
• Analysis of studies investigating microRNA expression in cardiac development and CHDs.
• Synthesis of evidence linking miRs to cardiovascular disease pathogenesis.

Main Results:

• MicroRNAs (miRs) play a crucial role in regulating gene expression during complex cardiac tissue formation.
• Altered miR expression levels are associated with various human cardiovascular diseases, including congenital heart diseases (CHDs).
• Experimental models provide evidence for the link between miRs and heart development anomalies.

Conclusions:

• MicroRNAs (miRs) are significant regulators of heart development and are implicated in the etiology of congenital heart diseases (CHDs).
• The correlation between miRs and heart development suggests their potential as diagnostic biomarkers for cardiovascular diseases.
• Further research into miRs is crucial for advancing personalized management and treatment strategies for CHD patients.